ELEVATE 2: Baseline Demographic Characteristics From the Phase IIB Study of the Efficacy and Safety of Two Doses of Rodatristat Ethyl When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension
A. Skride, J. Feldman, O. Shlobin, S. Sahay, J. Denning, W. Kamau-Kelley, G. Gareth, R. Jones, R. Grewal, S. Hoffman, H. Lazarus, O. Sitbon
{"title":"ELEVATE 2: Baseline Demographic Characteristics From the Phase IIB Study of the Efficacy and Safety of Two Doses of Rodatristat Ethyl When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension","authors":"A. Skride, J. Feldman, O. Shlobin, S. Sahay, J. Denning, W. Kamau-Kelley, G. Gareth, R. Jones, R. Grewal, S. Hoffman, H. Lazarus, O. Sitbon","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3781","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"40 13","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3781","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}